Dogwood Therapeutics DWTX Income Statement (2020-2026)

NASDAQ DWTX
$2.33 +0.02 (+0.87%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
3.21M2.96M2.92M2.77M2.41M1.62M1.27M0.50M0.56M0.37M0.30M0.34M0.34M0.54M2.32M2.44M2.57M14.52M2.34M2.67M
Selling, General & Administrative (Quarter)
1.08M1.15M1.27M1.19M1.27M0.97M0.82M1.06M0.92M0.90M0.84M0.97M0.73M1.77M5.23M1.99M1.35M1.29M1.47M2.41M
Operating Expenses (Quarter)
4.28M4.11M4.19M3.96M3.67M2.59M2.09M1.56M1.48M1.27M1.14M1.31M1.07M2.30M7.54M4.43M3.92M15.81M3.81M5.08M
Operating Income (Quarter)
-4.28M-4.11M-4.19M-3.96M-3.67M-2.59M-2.09M-1.56M-1.48M-1.27M-1.14M-1.31M-1.07M-2.30M-7.54M-4.43M-3.92M-15.81M-3.81M-5.08M
EBIT (Quarter)
-4.28M-4.11M-4.19M-3.96M-3.67M-2.59M-2.09M-1.56M-1.48M-1.27M-1.14M-1.31M-1.07M-2.30M-7.54M-4.43M-3.92M-15.81M-3.81M-5.08M
Non-operating items
Other Non Operating Income (Quarter)
0.00M0.00M-0.32M906.000.00M0.02M0.05M0.04M0.04M0.04M0.03M0.02M0.02M0.02M-0.09M-6.13M0.00M0.06M-0.01M
Non Operating Income (Quarter)
0.04M0.04M0.03M0.02M0.02M0.02M-0.16M-0.15M0.11M0.08M0.05M0.08M
Net income details
EBT (Quarter)
-4.28M-4.11M-4.51M-3.96M-3.67M-2.58M-2.04M-1.52M-1.44M-1.24M-1.10M-1.29M-1.05M-2.28M-7.73M-10.73M-3.81M-0.42M-32.45M-0.11M
Profit After Tax (Quarter)
-4.28M-4.11M-4.51M-3.96M-3.67M-2.58M-2.04M-1.52M-1.44M-1.24M-1.10M-1.29M-1.05M-2.28M-11.59M-10.86M-3.81M-17.11M-6.01M-6.12M
Income from Non-Controlling Interests (Quarter)
0.02M
Income from Continuing Operations (Quarter)
-4.28M-4.11M-4.51M-3.96M-3.67M-2.58M-2.04M-1.52M-1.44M-1.24M-1.10M-1.29M-1.05M-2.28M-7.73M-10.73M-3.81M-0.42M-32.45M-0.11M
Consolidated Net Income (Quarter)
-4.28M-4.11M-4.51M-3.96M-3.67M-2.58M-2.04M-1.52M-1.44M-1.24M-1.10M-1.29M-1.05M-2.28M-7.73M-10.73M-3.81M-0.42M-32.45M-0.11M
Income towards Parent Company (Quarter)
-4.28M-4.11M-4.51M-3.96M-3.67M-2.58M-2.04M-1.52M-1.44M-1.24M-1.10M-1.29M-1.05M-2.28M-7.73M-10.73M-3.81M-0.42M-32.45M-0.11M
Net Income towards Common Stockholders (Quarter)
-4.28M-4.11M-4.51M-3.96M-3.67M-2.58M-2.04M-1.52M-1.44M-1.24M-1.10M-1.29M-1.05M-2.28M-8.24M-12.18M-3.81M-15.74M-3.78M-4.99M
Additional items
EPS (Basic) (Quarter)
-12.85-12.33-13.54-11.89-11.01-7.00-4.62-2.07-1.96-1.62-1.47-1.68-1.15-2.05-8.02-8.45-1.99-8.20-0.76-0.15
EPS (Diluted) (Quarter)
-12.85-12.33-13.54-11.89-11.01-7.00-4.62-2.07-1.96-1.62-1.47-1.68-1.15-2.05-8.02-8.45-1.99-8.20-0.76-0.15
Shares Outstanding (Quarter)
0.33M0.33M0.33M0.33M0.33M0.37M0.44M0.73M0.74M0.76M0.75M0.77M0.92M1.11M1.03M1.44M1.91M1.92M4.98M33.54M
Shares Outstanding (Diluted) (Quarter)
0.33M0.33M0.33M0.33M0.33M0.37M0.44M0.73M0.74M0.76M0.75M0.77M0.92M1.11M1.03M1.44M1.91M1.92M4.98M33.54M
Shares Outstanding (Entity) (Quarter)
0.33M0.33M0.33M0.33M0.33M0.37M0.44M0.73M0.74M0.77M0.77M0.77M0.92M1.11M1.03M1.44M1.91M2.29M4.98M33.40M
EBITDA (Quarter)
-4.28M-4.11M-4.19M-3.96M-3.67M-2.59M-2.09M-1.56M-1.48M-1.27M-1.14M-1.31M-1.07M-2.30M-7.54M-4.43M-3.92M-15.81M-3.81M-5.08M
Interest Expenses (Quarter)
0.06M0.72M0.42M0.19M0.18M0.03M0.03M0.03M0.03M0.03M0.03M